FENTANYL PHARMACOKINETICS IN ANAESTHETIZED PATIENTS WITH CIRRHOSIS
نویسندگان
چکیده
منابع مشابه
Fleroxacin pharmacokinetics in patients with liver cirrhosis.
In this open-label study, the disposition of fleroxacin in liver disease in 12 healthy male volunteers, 6 male cirrhotics without ascites (group A), and 6 male cirrhotics with ascites (group B) was evaluated. Fleroxacin (400 mg) was administered orally and intravenously to each subject in a random crossover fashion. Fleroxacin was completely absorbed and achieved similar peak concentrations in ...
متن کاملFentanyl decreases end-expiratory lung volume in patients anaesthetized with sevoflurane.
BACKGROUND In patients breathing spontaneously during anaesthesia, expiratory muscle activity can be a prominent feature. This activity is triggered or exaggerated by opioid administration, which causes a prompt increase in intra-abdominal pressure. The effect of this increased expiratory activity on end-expiratory lung volume is not described. METHODS Nine patients having minor gynaecologica...
متن کاملClinical pharmacokinetics of adriamycin in hepatoma patients with cirrhosis.
patients with liver dysfunction, plasma AD levels have been found to be elevated and prolonged (5). This elevation and prolongation of plasma AD levels was found to correlate with the elevation of bilinubin, and the ob servation has led to an empirical index for dose adjustments on the basis of liven function as determined by bilirubin and transaminase levels (2). The phanmacokinetic studies us...
متن کاملPharmacokinetics and pharmacodynamics of rapacuronium in patients with cirrhosis.
BACKGROUND Delayed elimination kinetics of steroidal neuromuscular blocking agents have been observed in patients with cirrhosis. Like other steroidal muscle relaxants, rapacuronium may, in part, be eliminated by the liver. To determine the influence of liver disease on its neuromuscular blocking effect, we studied the pharmacokinetics and pharmacodynamics of rapacuronium in patients with cirrh...
متن کاملPharmacokinetics of atracurium and laudanosine in patients with hepatic cirrhosis.
The pharmacokinetic profiles of atracurium and one of its derivatives, laudanosine were studied following an i.v. bolus of atracurium 0.6 mg kg-1 administered to eight patients with hepatic cirrhosis and to seven healthy controls. The central volume of distribution of atracurium was greater in the patients with cirrhosis (104.6 ml kg-1) compared with the controls (69.6 ml kg-1) (P less than 0.0...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Anaesthesia
سال: 1982
ISSN: 0007-0912
DOI: 10.1093/bja/54.12.1267